Correlation Between PT Astra and Cannara Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both PT Astra and Cannara Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PT Astra and Cannara Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PT Astra International and Cannara Biotech, you can compare the effects of market volatilities on PT Astra and Cannara Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PT Astra with a short position of Cannara Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of PT Astra and Cannara Biotech.

Diversification Opportunities for PT Astra and Cannara Biotech

-0.56
  Correlation Coefficient

Excellent diversification

The 3 months correlation between PTAIF and Cannara is -0.56. Overlapping area represents the amount of risk that can be diversified away by holding PT Astra International and Cannara Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cannara Biotech and PT Astra is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PT Astra International are associated (or correlated) with Cannara Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cannara Biotech has no effect on the direction of PT Astra i.e., PT Astra and Cannara Biotech go up and down completely randomly.

Pair Corralation between PT Astra and Cannara Biotech

Assuming the 90 days horizon PT Astra International is expected to under-perform the Cannara Biotech. But the pink sheet apears to be less risky and, when comparing its historical volatility, PT Astra International is 2.09 times less risky than Cannara Biotech. The pink sheet trades about -0.18 of its potential returns per unit of risk. The Cannara Biotech is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest  47.00  in Cannara Biotech on October 25, 2024 and sell it today you would earn a total of  15.00  from holding Cannara Biotech or generate 31.91% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy98.33%
ValuesDaily Returns

PT Astra International  vs.  Cannara Biotech

 Performance 
       Timeline  
PT Astra International 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days PT Astra International has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's forward indicators remain nearly stable which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
Cannara Biotech 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Cannara Biotech are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile technical and fundamental indicators, Cannara Biotech reported solid returns over the last few months and may actually be approaching a breakup point.

PT Astra and Cannara Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with PT Astra and Cannara Biotech

The main advantage of trading using opposite PT Astra and Cannara Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PT Astra position performs unexpectedly, Cannara Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cannara Biotech will offset losses from the drop in Cannara Biotech's long position.
The idea behind PT Astra International and Cannara Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Equity Valuation
Check real value of public entities based on technical and fundamental data
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency